Volume 67, Issue 4, Pages (April 2005)

Slides:



Advertisements
Similar presentations
Urea and nitrogen excretion in pediatric peritoneal dialysis patients
Advertisements

Acid-base profile in patients on PD
Home care assistance and the utilization of peritoneal dialysis
A skeptical view of assisted home peritoneal dialysis
Volume 59, Issue 4, Pages (April 2001)
Improved patient/technique survival and peritonitis rates in patients treated with automated peritoneal dialysis when compared to continuous ambulatory.
Volume 66, Issue 6, Pages (December 2004)
Beta blockers in the management of chronic kidney disease
Volume 69, Issue 5, Pages (March 2006)
Iron status and iron supplementation in peritoneal dialysis patients
Acid-base profile in patients on PD
Role of diuretics in the preservation of residual renal function in patients on continuous ambulatory peritoneal dialysis  James F. Medcalf, Kevin P.G.
Long-term follow-up of patients randomized to biocompatible or conventional peritoneal dialysis solutions show no difference in peritonitis or technique.
Impact of new dialysis solutions on peritonitis rates
Volume 64, Pages S3-S12 (December 2003)
Incremental peritoneal dialysis: Effects on the choice of dialysis modality, residual renal function and adequacy  G. Viglino, L. Neri, S. Barbieri  Kidney.
Volume 68, Issue 6, Pages (December 2005)
Volume 80, Issue 10, Pages (November 2011)
Glucose sparing in peritoneal dialysis: Implications and metrics
Fluid overload and residual renal function in peritoneal dialysis: the proof of the pudding is in the eating  Wim Van Biesen, Achim Jörres  Kidney International 
Volume 71, Issue 8, Pages (April 2007)
Hypoglycaemia in diabetes
Volume 78, Issue 6, Pages (September 2010)
Comorbidity and confounding in end-stage renal disease
A new era in phosphate binder therapy: What are the options?
Volume 67, Issue 5, Pages (May 2005)
Measuring transport of water across the peritoneal membrane
Severe exfoliative skin rash with icodextrin
What really happens to people on long-term peritoneal dialysis?
Volume 73, Issue 7, Pages (April 2008)
D. Coyne  Kidney International  Volume 69, Pages S1-S3 (May 2006)
The epidemiology of chronic kidney disease
Volume 73, Pages S5-S17 (April 2008)
Volume 73, Pages S94-S101 (April 2008)
Improved patient/technique survival and peritonitis rates in patients treated with automated peritoneal dialysis when compared to continuous ambulatory.
Volume 61, Issue 4, Pages (April 2002)
Volume 73, Issue 12, Pages (June 2008)
Structure, not just function
Alfonso M. Cueto-Manzano, Héctor R
Volume 69, Issue 12, Pages (June 2006)
Volume 69, Issue 3, Pages (February 2006)
Nephrology Crossword: Peritoneal Dialysis
Future of icodextrin as an osmotic agent in peritoneal dialysis
Environmental exposure to lead and progressive diabetic nephropathy in patients with type II diabetes  J.-L. Lin, D.-T. Lin-Tan, C.-C. Yu, Y.-J. Li, Y.-Y.
Nephrology Crossword: Glomerulonephritis
Volume 73, Pages S72-S75 (April 2008)
Higher serum C-reactive protein predicts short and long-term outcomes in peritoneal dialysis-associated peritonitis  N.-Y. Zalunardo, C.-L. Rose, I.W.Y.
A skeptical view of assisted home peritoneal dialysis
Quality of life in peritoneal dialysis patients: Decline over time and association with clinical outcomes  Sr. Anne B. Bakewell, Rob M. Higgins, Mair.
Daily nocturnal home hemodialysis
Urea and nitrogen excretion in pediatric peritoneal dialysis patients
Peter G. Blake, Arsh K. Jain, Sechelle Yohanna  Kidney International 
Volume 63, Pages S79-S82 (June 2003)
Organ transplantation goes to the movies
Volume 70, Pages S84-S90 (November 2006)
Volume 83, Issue 4, Pages (April 2013)
Adequacy of automated peritoneal dialysis with and without manual daytime exchange: A randomized controlled trial  D. Demetriou, A. Habicht, M. Schillinger,
Volume 59, Issue 4, Pages (April 2001)
Volume 70, Issue 7, Pages (October 2006)
Charles A. Herzog  Kidney International 
ANCA comes of age—but with caveats
Review of clinical trial experience with icodextrin
Volume 70, Issue 5, Pages (September 2006)
Volume 75, Issue 7, Pages (April 2009)
Volume 62, Issue 5, (November 2002)
Erratum Kidney International Volume 61, Issue 4, (April 2002)
The International Pediatric Peritonitis Registry: Starting to walk
Volume 69, Issue 8, Pages (April 2006)
Evaluation of the Losartan in Hemodialysis (ELHE) Study
Volume 57, Issue 4, Pages (April 2000)
Presentation transcript:

Volume 67, Issue 4, Pages 1609-1615 (April 2005) Longitudinal membrane function in functionally anuric patients treated with APD: Data from EAPOS on the effects of glucose and icodextrin prescription  Simon J. Davies, Edwina A. Brown, Niels E. Frandsen, Anabela S. Rodrigues, Ana Rodriguez-Carmona, Andreas Vychytil, Evelyne Macnamara, Agneta Ekstrand, Anders Tranaeus, Jose C. Divino Filho  Kidney International  Volume 67, Issue 4, Pages 1609-1615 (April 2005) DOI: 10.1111/j.1523-1755.2005.00243.x Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 1 Longitudinal membrane function for the whole patient cohort. Each data point represents the mean values (±SE) for the patients who remained in the study for the full two years. (For longitudinal paired statistics and mean values for all patients at each time point, see Table 3). Kidney International 2005 67, 1609-1615DOI: (10.1111/j.1523-1755.2005.00243.x) Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 2 Longitudinal membrane function according to baseline glucose exposure, patients using 1.36% only (□), 2.27% or 3.86% (•). As indicated in Figure 1, data points represent paired mean values (±SE) for patients remaining throughout the study that move from left to right at baseline, 12 and 24 months. (For longitudinal paired statistics and mean values for all patients at each time point, see Table 3). Kidney International 2005 67, 1609-1615DOI: (10.1111/j.1523-1755.2005.00243.x) Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 3 Longitudinal membrane function according to baseline use of icodextrin (•) or no icodextrin (□). As indicated in Figure 1, data points represent paired mean values (±SE) for patients remaining throughout the study that move from left to right at baseline, 12 and 24 months. (For longitudinal paired statistics and mean values for all patients at each time point, see Table 3). Kidney International 2005 67, 1609-1615DOI: (10.1111/j.1523-1755.2005.00243.x) Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 4 Longitudinal membrane function according to whether patients experienced no peritonitis (□) or one or more episodes (•). As indicated in Figure 1, data points represent paired mean values (±SE) for patients remaining throughout the study that move from left to right at baseline, 12 and 24 months. Significant changes longitudinal changes occur in both groups, and appear more rapid and severe in the peritonitis group, but between group comparisons are not statistically significant. Kidney International 2005 67, 1609-1615DOI: (10.1111/j.1523-1755.2005.00243.x) Copyright © 2005 International Society of Nephrology Terms and Conditions